Cytely Raises €3 Million to Transform Laboratory Microscopy
In a significant development for the scientific community, the Lund-based startup, Cytely, has successfully raised €3 million in a recent funding round aimed at expanding its groundbreaking smart microscopy platform. This technology is designed to convert conventional laboratory microscopes into dynamic data analysis tools, effectively reducing the time researchers spend on manual evaluations by 75%. The funding round was spearheaded by Ugly Duckling Ventures, with ongoing support from existing investor Icebreaker.vc. Cytely, which is affiliated with the SmiLe Venture Hub, operates with teams in multiple locations, including San Diego and Singapore.
Innovative Solutions for Scientific Workflows
The co-founder and CEO of Cytely, Philip Nordenfelt, emphasized how traditional workflows have been limited by a focus on imaging rather than data. He articulated that their platform enables a transition from simply obtaining images to generating real-time measurements, thus facilitating quicker experimental decision-making. The ultimate aim, according to Nordenfelt, is to ensure that every experiment is ready for analysis right from its inception, thereby enabling a cumulative approach to scientific discoveries.
The current funding is part of a broader trend in European DeepTech and HealthTech sectors, where startups are increasingly focusing on automation and data-driven research methodologies. Other notable funding rounds include QT Sense from the Netherlands, which raised €6 million for its quantum-sensing innovations, and Pixel Photonics from Germany, which received €1 million to enhance its microscopy diagnostics.
Enhancing Access to Advanced Microscopy
Founded in 2023, Cytely specializes in creating tools that facilitate biological exploration through data-centric approaches. Their platform automates the capture, processing, and analysis of complex cellular data, making the traditionally labor-intensive microscopy process not only faster but also more statistically reliable. This innovation opens up new avenues for laboratories that previously lacked access to advanced imaging technologies.
The impact of Cytely‘s technology is already being felt in various prestigious research institutions, including Lund University, where it is being applied in the fields of virology, oncology, and metabolic research. Dr. Vinay Swaminathan, who leads the Laboratory of Cell & Molecular Mechanobiology at Lund University, described Cytely‘s software as a democratizing force in science, suggesting it liberates scientific discovery from the constraints of funding, thus enabling any researcher to confront significant health challenges.
Real-World Applications and Results
Historically, microscopy analysis has relied heavily on static images, with researchers often spending weeks manually evaluating individual cells, resulting in data that lacked statistical confidence. Cytely seeks to alter this model by prioritizing data over images, automating the acquisition of images, quantifying entire samples, and delivering standardized and reproducible results in real time. Their platform is compatible with most modern microscopes, negating the need for expensive specialized equipment.
The practical benefits of this technology are evident; a cancer research facility reported a 75% reduction in analysis time, translating to savings of approximately €300,000 annually. Additionally, a nanowire biotech company noted a 40% increase in R&D efficiency, estimating an added value of $1 million per year. Another institution opted to replace a costly high-throughput imaging system with Cytely‘s platform, showcasing the versatility and cost-effectiveness of their solution.
With the newly acquired funding, Cytely plans to develop intelligent acquisition tools compatible with various microscope brands and streamline workflows to assist researchers regardless of their data analysis proficiency. These advancements will foster a collaborative discovery network where validated protocols and datasets can be shared, ultimately paving the way for predictive analyses and partially autonomous research.
Louise Lachmann, a partner at Ugly Duckling Ventures, expressed enthusiasm about the project, highlighting its transformative potential and the importance of making smart, data-centric microscopy accessible to laboratories everywhere. This funding marks a pivotal moment for Cytely as it continues to innovate within the scientific landscape.
Related
